The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

アメリカ食品医薬品局には、市販薬と処方薬の審査を担当する部局として「医薬品評価研究センター (CDER)」という部署があり、「cderGPT」という名称はCDERから取られたものと考えられます。 Center for Drug Evaluation ...

The Food and Drug Administration is going all in on artificial intelligence. Commissioner Martin Makary, M.D., has instructed all the agency’s centers to fully integrate generative AI into their ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of ...

Calling it a “historic first,” FDA commissioner Marty Makary said on Thursday that the AI tool will be deployed across all of the agency’s review offices by the end of June, following the ...

“We’ve just completed our first AI-assisted scientific review for a product and that’s just the beginning,” he added. Meanwhile, Wired reported this week that FDA officials have been ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of constantly ...

OpenAI has met with officials from the U.S. Food and Drug Administration (FDA) to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the ...